Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Does Gluco6 really work… or is it just another overhyped capsule making big promises? The claims are bold. According to the ...
Researchers at Umeå University have discovered that the SARS-CoV-2 variant omicron has developed a stronger binding to human ...
FDA meeting to align on myositis registrational trial designs for rese-cel in 1H25 on track –– Enrolling approximately one patient per week ...
While Novartis and Bayer got there first, AstraZeneca, Bristol Myers Squibb and Eli Lilly are all vying to bring their ...
G Protein-Coupled Receptors (GPCRs) in advancing GPCR-targeted therapies, including the use of agonists, antagonists, biased ...
4d
Stocktwits on MSNPortage Biotech’s After-Hours Surge On Preclinical Tumor Trial Data Sends Retail Optimism Sky-HighShares of Portage Biotech Inc. more than doubled in after-hours trading on Thursday as the company reported promising ...
Cell membrane proteins hide secret gateways that can be used to modify cell behavior. This has been demonstrated in a study led by the Hospital del Mar Research Institute and published in Nature ...
A clinical team has spearheaded the use of CAR-T cell therapy for blood cancers. The researchers recently treated the first ...
Cell membrane proteins hide secret gateways that can be used to modify cell behavior. This has been demonstrated in a study ...
Septerna Provides Corporate Overview and Reports Fourth Quarter and Full Year 2024 Financial Results
Corporate Updates: In January 2025, Septerna appointed Gil Labrucherie, CFA, J.D., as chief financial officer. Mr. Labrucherie is a seasoned biopharma executive with more than 25 years of senior ...
Delve into the kinase inhibitors' diverse landscape, from cancer breakthroughs to autoimmune disease innovations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results